MiniMed (MMED) makes a decisive move with FDA-approved 'Flex' pump... maintaining 80% blood sugar, securing $538 million IPO

MiniMed (MMED) is strengthening its attack on the diabetes management market with next-generation insulin delivery devices and clinical data, set to unveil the new 'MiniMed Flex' pump and smart insulin pen 'MiniMed Go' at an upcoming conference.

Get the next 8/10 catalyst

Telegram alerts when our AI scores a story 8+/10 (~1-3 per day, no spam). Verified 30d hit rate 49.8%.

Join Telegram channel or scan with phone →